0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Fish-Oil Fatty Acid Supplementation in Active Rheumatoid Arthritis: A Double-Blinded, Controlled, Crossover Study

JOEL M. KREMER, M.D.; WILLIAM JUBIZ, M.D.; ANN MICHALEK, M.D.; RICHARD I. RYNES, M.D.; LEE E. BARTHOLOMEW, M.D.; JEAN BIGAOUETTE, R.D.; MARYANN TIMCHALK, B.S.; DONALD BEELER, Ph.D.; and LLOYD LININGER, Ph.D.
[+] Article and Author Information

Grant support: in part by grant #5MO1RR00749-13 from the National Institutes of Health, and by the Research Service of the Veterans Administration.

▸Requests for reprints should be addressed to Joel M. Kremer, M.D.; Division of Rheumatology, Albany Medical College, 47 New Scotland Avenue; Albany, NY 12208.


© 1987 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1987;106(4):497-503. doi:10.7326/0003-4819-106-4-497
Text Size: A A A

Study Objective: To determine the efficacy of fish-oil dietary supplements in active rheumatoid arthritis and their effect on neutrophil leukotriene levels.

Design: Nonrandomized, double-blinded, placebo-controlled, crossover trial with 14-week treatment periods and 4-week washout periods.

Setting: Academic medical center, referral-based rheumatology clinic.

Patients: Forty volunteers with active, definite, or classical rheumatoid arthritis. Five patients dropped out, and two were removed for noncompliance.

Interventions: Treatment with nonsteroidal anti-inflammatory drugs, slow-acting antirheumatic drugs, and prednisone was continued. Twenty-one patients began with a daily dosage of 2.7 g of eicosapaentanoic acid and 1.8 g of docosahexenoic acid given in 15 MAX-EPA capsules (R.P. Scherer, Clearwater, Florida), and 19 began with identical-appearing placebos. The background diet was unchanged.

Measurements and Main Results: The following results favored fish oil over placebo after 14 weeks: mean time to onset of fatigue improved by 156 minutes (95% confidence interval, 1. 2 to 311.0 minutes), and number of tender joints decreased by 3.5 (95% Cl, -6.0 to -1.0). Other clinical measures favored fish oil as well but did not reach statistical significance. Neutrophil leukotriene B4 production was correlated with the decrease in number of tender joints (Spearman rank correlation r = 0.53; p < 0.05). There were no statistically significant differences in hemoglobin level, sedimentation rate, or presence of rheumatoid factor or in patient-reported adverse effects. An effect from the fish oil persisted beyond the 4-week washout period.

Conclusions: Fish-oil ingestion results in subjective alleviation of active rheumatoid arthritis and reduction in neutrophil leukotriene B4 production. Further studies are needed to elucidate mechanisms of action and optimal dose and duration of fish-oil supplementation.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)